The CoE in Convergent Bio-Nano Science &Technology comprises a multi-disciplinary team focused on research aiming to understand and control the interface of materials with biological systems. The Centre will exploit knowledge of the bio-nano interface to design materials that transport and deliver vaccines, drugs and gene therapy agents, and to design new diagnostic agents and devices. Nanomedicines are on the cusp of revolutionizing diagnosis and therapy in many diseases. The CoE will be the focus of bio-nano research activity in Australia, uniting universities, research agencies, institutes and companies. The expected outcomes are better diagnostic and therapeutic tools designed via an enhanced understanding of the bio-nano-interface.

Funding:$26 million over 7 years

Centre Director: Professor Thomas Davis

Administering Organisation: Monash University

Collaborating and Partner Organisations:

  • The University of Melbourne
  • The University of New South Wales
  • The University of Queensland
  • University of South Australia
  • Australian Nuclear Science and Technology Organisation
  • Imperial College London
  • Memorial Sloan-Kettering Cancer Center
  • Sung Kyun Kwan University
  • The University of Nottingham
  • University College Dublin
  • University of California, Santa Barbara
  • University of Warwick, UK
  • University of Wisconsin, Madison
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology logo

Please visit the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology website for further information.